Early antibody response to SARS-CoV-2
View ORCID ProfileRuggero Dittadi, Haleh Afshar, Paolo Carraro
doi: https://doi.org/10.1101/2020.05.19.20099317
Ruggero Dittadi
Laboratory Medicine, Ospedale dell’Angelo, ULSS3 Serenissima, Mestre, Venice, Italy
Haleh Afshar
Laboratory Medicine, Ospedale dell’Angelo, ULSS3 Serenissima, Mestre, Venice, Italy
Paolo Carraro
Laboratory Medicine, Ospedale dell’Angelo, ULSS3 Serenissima, Mestre, Venice, Italy
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data of the present study are available
Posted May 22, 2020.
Early antibody response to SARS-CoV-2
Ruggero Dittadi, Haleh Afshar, Paolo Carraro
medRxiv 2020.05.19.20099317; doi: https://doi.org/10.1101/2020.05.19.20099317
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2649)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12229)
- Forensic Medicine (10)
- Gastroenterology (760)
- Genetic and Genomic Medicine (4105)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2658)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (438)
- Neurology (3884)
- Nursing (209)
- Nutrition (578)
- Oncology (2033)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6532)
- Radiology and Imaging (1405)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (449)
- Toxicology (53)
- Transplantation (185)
- Urology (165)